GSK Drops as RSV Shot Suffers Fresh Blow With US Recommendation

GSK Drops as RSV Shot Suffers Fresh Blow With US RecommendationH&M Profit Misses as Summer Collections Fail to Lure ShoppersChina to Hold Delayed Party Meeting on Reform From July 15 to 18UK Patients Get Access to One of World’s Most Expensive DrugsTop Lobbyist Sees London Gaining Edge With France, US ElectionsNew World Tells Investors It Will Try to Pay Perp Bond Next YearBillionaire Birla’s UltraTech to Acquire 23% in India CementsIndian Financiers’ Debt Lures Buyers on Widest Spread...

Now 16 Million Thames Water Users are Picking Up the BillNumber of US Kids Has Fallen Since Pandemic, Except in FloridaNorth Korea Claims Success in Test for Multiple Warhead MissileMajority of Thais Back Plan to Label Cannabis as Narcotics AgainEx-Trump Associate Felix Sater Loses NY Money-Laundering TrialKenya President Bends to Pressure, Scraps $2.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna’s RSV Shot Wins FDA Approval for Use in Older AdultsModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech a second product as it seeks to move beyond its reliance on the fading Covid-19 market.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

GSK stock sinks after court allows Zantac lawsuits to proceedShares of Britain-based pharmaceutical company GSK plc (GSK) — formerly known as GlaxoSmithKline — are sliding in pre-market trading and into Monday's...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »